Literature DB >> 22308581

Progress in global measles control, 2000–2010.

.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22308581

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  4 in total

1.  Do Australian immunoglobulin products meet international measles antibody titer standards?

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

2.  Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases.

Authors:  Annelies W Mesman; Esther M Zijlstra-Willems; Tanja M Kaptein; Rik L de Swart; Meredith E Davis; Martin Ludlow; W Paul Duprex; Michaela U Gack; Sonja I Gringhuis; Teunis B H Geijtenbeek
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

3.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

4.  Persistence of measles neutralizing antibody related to vaccine and natural infection acquired before HIV infection.

Authors:  M B Isa; J V Pavan; P Sicilia Don; S Grutadauria; L C Martinez; M O Giordano; G Masachessi; P A Barril; S V Nates
Journal:  Epidemiol Infect       Date:  2013-10-21       Impact factor: 4.434
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.